From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit
| Autor: | Lythgoe, Mark P *, Krell, Jonathan, Bower, Mark, Murphy, Ravindhi, Marriott, John, Blagden, Sarah P, Aggarwal, Ajay, Sullivan, Richard |
|---|---|
| Zdroj: | In The Lancet Oncology April 2023 24(4):e150-e160 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|